Guest Column

29 More Days Isn't a Business Plan (Opinion)

The one-month reprieve on the impending ban on many hemp products doesn't give small businesses enough time to make the decisions required to keep their companies running. Dylan Raap, CEO and founder of cannabis and hemp business Upstate Elevator, asks Congress to ‘tell us what the rules are and give us enough runway to live by them.’

The Hemp Loophole Is Closing, But We Still Need to Fix What It Broke (Opinion)

Congress is finally moving to regulate hemp-derived THC. Licensed cannabis operators have been waiting years for this moment. Now we need to make sure it actually sticks.

Medical Cannabis at Inflection Point: Policy, Science, What Comes Next (Opinion)

From New York’s clinical leadership to emerging product standards, patient care is becoming the market’s north star.

Hemp Ban Leaves Vulnerable Animals With No Path to Peace (Opinion)

Renowned founder of The Asher House animal sanctuary and Asher House Wellness explains the agricultural FDA spending bill’s devastating impact on animals’ chance at peace and happiness offered by CBD.

ESOPs for Cannabis Operators: A Fix for the 280E Problem?

Employee Stock Ownership Plans can benefit cannabis companies, business owners, and employees, but downsides exist, and the rules are intricate.

When Polarization Replaces Governance: Cannabis Rescheduling and the Cost of Fear-Based Leadership (Opinion)

Much of the industry conversation to Trump’s executive order defaults to doom narratives that generate engagement but produce minimal legislative leverage.

San Francisco Rediscovers Its Cannabis Roots, Offers California a Blueprint for Revival (Opinion)

The city’s Board of Supervisors voted to suspend its local cannabis business tax until Dec. 31, 2035.

Closing the Hemp Loophole Does Not Mean Your Business Has to Close (Opinion)

Potential changes to the 2018 Farm Bill’s definition of hemp, if enacted, mean businesses will have one year to adapt their operations.

Hemp Regulation Should Protect People, Not Punish Progress (Opinion)

The new agricultural FDA spending bill threatens to ban nearly all hemp-derived products in today's market.

Cannabis Ventures, Start-Up Best Practices, and Ways to Compete

Most successful start-ups are taking a cautious and conservative approach to their build-outs and are properly capturing costs.

Inventory Costing: One of Cannabis’s Most Misunderstood and Financially Critical Business Processes

By approaching inventory costing strategically—not just as a back-office task—cannabis businesses can strengthen tax compliance and operational efficiency, and support long-term growth.

The Race to Nowhere: How Chasing Potency Undermines Cannabis Quality (Opinion)

The current THC labeling system is misleading, and consumers deserve more accurate, meaningful information.

Page 1 of 9

Next Page